Target intelligence / Profile preview

Intestinal glucose transporter and sweet taste receptor

Molecular classification
Transporter (SGLT1, GLUT2, GLUT5), G protein-coupled receptor (T1R2, T1R3), Receptor (Sweet taste receptor)
01

Overview

The intestinal glucose transporters and sweet taste receptors are a collection of membrane proteins expressed in the gut epithelium and enteroendocrine cells that regulate the sensing, absorption, and signaling of dietary sugars. Key transporters include sodium-glucose cotransporter 1 (SGLT1), responsible for active glucose uptake; facilitative glucose transporter type 2 (GLUT2) for high-capacity glucose transport; and GLUT5, a key fructose transporter. Intestinal sweet taste receptors are primarily formed by a heterodimer of taste receptor type 1 members 2 and 3 (T1R2/T1R3), which are G protein-coupled receptors (GPCRs) mediating the detection of sugars and sweeteners. Activation of these receptors not only contributes to nutrient sensing and gut hormone secretion (notably GLP-1 and GLP-2), but also dynamically regulates the abundance and localization of glucose transporters in response to dietary carbohydrates. These pathways are critical for glucose homeostasis, and alterations in their expression or function are implicated in metabolic diseases such as diabetes and obesity. SGLT1 is a validated therapeutic target, and various sweet taste receptor components are being explored for their potential role in modulating glycemic control and satiety responses[1][3][4][5][7]. Note: The query combines multiple distinct protein families (transporters and receptors) into a single entry; these are best considered as separate targets. Current conventions would treat SGLT1, GLUT2, and sweet taste receptor (T1R2/T1R3) as individual, canonical targets, not grouped as "Intestinal glucose transporters and sweet taste receptors."

Other names
SGLT1Sodium-glucose cotransporter 1GLUT2Glucose transporter type 2GLUT5Glucose transporter type 5T1R2Taste receptor type 1 member 2T1R3Taste receptor type 1 member 3Sweet taste receptor
02

Mechanism of action

Inhibition of SGLT1 blocks glucose absorption in the intestine, reducing blood glucose levels[6] - SGLT2 inhibition reduces renal glucose reabsorption, with mild intestinal effects[6] - Activation of sweet taste receptors T1R2/T1R3 triggers intracellular GPCR signaling cascades, leading to gut hormone secretion and upregulation/insertion of glucose transporters (notably GLUT2 and SGLT1)[3][4][5]

03

Biological functions

Glucose absorption/transport across intestinal epitheliumSweet sensing/chemosensory signal transductionRegulation of glucose homeostasisModulation of gut hormone secretion (e.g., GLP-1, GLP-2, GIP)[1][3][4][5]
04

Disease associations

Diabetes mellitus and glycemic dysregulationObesity and metabolic syndromeGastrointestinal functional disordersOther metabolic diseases[3][4][7]
05

Safety considerations

Inhibition of intestinal glucose transporters can cause diarrhea, malabsorption, dehydration in some individuals[6]SGLT1/2 dual inhibitors may increase risk of gastrointestinal adverse effects (e.g., diarrhea)[6]Individual responses to sweeteners vary and may affect glycemic control[7]
06

Interacting drugs

SGLT1 inhibitors (e.g., phlorizin, sotagliflozin)

3 more in the full profile.

07

Biomarkers

Intestinal expression levels of SGLT1, GLUT2 (for metabolic status)Gut hormone levels (GLP-1, GLP-2, GIP) after sugar or sweetener challenge[4]

Beyond the preview

Go deeper on Intestinal glucose transporter and sweet taste receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal glucose transporter and sweet taste receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call